Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
09 2020
Historique:
received: 02 05 2020
revised: 23 05 2020
accepted: 02 06 2020
pubmed: 12 7 2020
medline: 17 9 2020
entrez: 12 7 2020
Statut: ppublish

Résumé

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated coronavirus disease 2019 (COVID-19) pandemic has demanded rapid upscaling of in-vitro diagnostic assays to enable mass screening and testing of high-risk groups, and simultaneous ascertainment of robust data on past SARS-CoV-2 exposure at an individual and a population level. To meet the exponential demand in testing, there has been an accelerated development of both molecular and serological assays across a plethora of platforms. The present review discusses the current literature on these modalities, including nucleic acid amplification tests, direct viral antigen tests and the rapidly expanding laboratory-based and point of care serological tests. This suite of complementary tests will inform crucial decisions by healthcare providers and policy makers, and understanding their strengths and limitations will be critical to their judicious application for the development of algorithmic approaches to treatment and public health strategies.

Identifiants

pubmed: 32651106
pii: S1472-6483(20)30318-7
doi: 10.1016/j.rbmo.2020.06.001
pmc: PMC7293848
pii:
doi:

Substances chimiques

Antigens, Viral 0
RNA, Viral 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

483-499

Informations de copyright

Crown Copyright © 2020. Published by Elsevier Ltd. All rights reserved.

Références

Public Health. 2020 May;182:170-172
pubmed: 32334183
J Med Virol. 2020 Oct;92(10):1724-1727
pubmed: 32227490
J Infect Dis. 2020 Jun 29;222(2):189-193
pubmed: 32382737
J Clin Virol. 2020 Jul;128:104393
pubmed: 32387968
J Med Virol. 2020 Oct;92(10):1975-1979
pubmed: 32320064
Clin Infect Dis. 2020 Nov 5;71(8):1930-1934
pubmed: 32306047
Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100747
pubmed: 33898863
J Clin Virol. 2020 Jul;128:104413
pubmed: 32403010
Sci China Life Sci. 2020 May;63(5):777-780
pubmed: 32270436
Clin Infect Dis. 2020 Nov 19;71(16):2255-2258
pubmed: 32337590
Clin Chem. 2020 Aug 1;66(8):1055-1062
pubmed: 32402061
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Int J Infect Dis. 2020 May;94:49-52
pubmed: 32251798
Am J Transl Res. 2020 Apr 15;12(4):1348-1354
pubmed: 32355546
J Infect. 2020 Aug;81(2):e53-e54
pubmed: 32335175
J Med Virol. 2020 Oct;92(10):2004-2010
pubmed: 32330303
Clin Transl Immunology. 2020 May 06;9(5):e01136
pubmed: 32382418
Exp Neurobiol. 2020 Apr 30;29(2):107-119
pubmed: 32156101
Arch Iran Med. 2020 Apr 01;23(4):268-271
pubmed: 32271601
Front Med (Lausanne). 2021 Mar 15;8:595773
pubmed: 33791320
Emerg Infect Dis. 2019 Oct;25(10):1868-1877
pubmed: 31423970
J Infect. 2020 Aug;81(2):e6-e10
pubmed: 32389784
J Clin Microbiol. 2004 Jun;42(6):2629-35
pubmed: 15184444
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Clin Chem Lab Med. 2020 Jun 25;58(7):1156-1159
pubmed: 32301750
J Infect. 2020 Jul;81(1):147-178
pubmed: 32209385
Emerg Microbes Infect. 2020 Dec;9(1):469-473
pubmed: 32102625
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Emerg Infect Dis. 2021 Feb;27(2):636-638
pubmed: 33349310
Clin Chim Acta. 2020 Aug;507:164-166
pubmed: 32343948
J Med Virol. 2020 Oct;92(10):1735-1738
pubmed: 32243608
Euro Surveill. 2020 May;25(18):
pubmed: 32400364
Clin Microbiol Infect. 2020 Oct;26(10):1386-1394
pubmed: 32603801
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2271-2277
pubmed: 32681308
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32381641
Ann Oncol. 2020 Aug;31(8):1087-1088
pubmed: 32360743
Euro Surveill. 2020 Oct;25(42):
pubmed: 33094713
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Euro Surveill. 2020 Apr;25(16):
pubmed: 32347204
Lancet Infect Dis. 2020 Apr;20(4):411-412
pubmed: 32105638
Int Immunopharmacol. 2020 Nov;88:106861
pubmed: 32771946
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
J Infect. 2020 Aug;81(2):e39-e45
pubmed: 32504735
BMJ. 2020 May 12;369:m1808
pubmed: 32398230
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Am J Emerg Med. 2020 Dec;38(12):2752
pubmed: 32386808
Clin Infect Dis. 2021 Jan 27;72(2):249-253
pubmed: 33501969
Clin Diagn Lab Immunol. 2005 Jan;12(1):135-40
pubmed: 15642998
Emerg Microbes Infect. 2020 Dec;9(1):940-948
pubmed: 32357808
J Med Virol. 2020 Oct;92(10):1795-1796
pubmed: 32311142
Eur Respir J. 2020 Aug 27;56(2):
pubmed: 32430429
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Front Med (Lausanne). 2021 Apr 12;8:569266
pubmed: 33912572
Clin Chem Lab Med. 2020 Jun 25;58(7):1081-1088
pubmed: 32301749
J Med Virol. 2020 Sep;92(9):1518-1524
pubmed: 32104917
J Med Virol. 2020 Apr;92(4):418-423
pubmed: 31967327
Nat Med. 2020 Aug;26(8):1196-1199
pubmed: 32641783
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Microbes Infect. 2020 May - Jun;22(4-5):206-211
pubmed: 32425648
Emerg Infect Dis. 2017 Jul;23(7):1079-1084
pubmed: 28585916
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
J Infect. 2020 Aug;81(2):e55-e58
pubmed: 32335168
Int J Epidemiol. 2021 May 17;50(2):410-419
pubmed: 33615345
Clin Infect Dis. 2020 Nov 19;71(16):2066-2072
pubmed: 32357209
J Med Virol. 2020 Sep;92(9):1671-1675
pubmed: 32330291
Clin Chem Lab Med. 2020 Jul 15;58(9):1601-1607
pubmed: 32609640
Ann Clin Biochem. 2020 Nov;57(6):429-434
pubmed: 32961061
J Clin Virol. 2020 Jul;128:104437
pubmed: 32434708
Infect Ecol Epidemiol. 2020 Apr 14;10(1):1754538
pubmed: 32363011
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32245835
Stat Med. 1997 May 15;16(9):981-91
pubmed: 9160493
J Infect. 2020 Jul;81(1):e28-e32
pubmed: 32283141
Emerg Microbes Infect. 2020 Dec;9(1):747-756
pubmed: 32196430

Auteurs

Antonio La Marca (A)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy. Electronic address: antlamarca@libero.it.

Martina Capuzzo (M)

Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.

Tiziana Paglia (T)

Department of Anesthesiology, Hesperia Hospital, Modena, Italy.

Laura Roli (L)

Department of Laboratory Medicine and Pathology, Azieda USL, Modena, Italy.

Tommaso Trenti (T)

Department of Laboratory Medicine and Pathology, Azieda USL, Modena, Italy.

Scott M Nelson (SM)

School of Medicine, University of Glasgow, Glasgow, UK; NIHR Bristol Biomedical Research Centre Bristol, UK; The Fertility Partnership, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH